首页> 外国专利> POLYMORPHISMS OF THE 5' REGION OF THE HUMAN 5-HT1A GENE, ASSOCIATED PROTEINS OF THE 5' REGION AND A DIAGNOSTIC TEST FOR MAJOR DEPRESSION AND RELATED MENTAL ILLNESSES

POLYMORPHISMS OF THE 5' REGION OF THE HUMAN 5-HT1A GENE, ASSOCIATED PROTEINS OF THE 5' REGION AND A DIAGNOSTIC TEST FOR MAJOR DEPRESSION AND RELATED MENTAL ILLNESSES

机译:人5-HT1A基因5'区域的多态性,5'区域的相关蛋白以及主要抑郁症和相关精神疾病的诊断测试

摘要

Clinical response to antidepressant compounds correlates with a selectivedown-regulation of presynaptic 5-HT1A receptors in serotonergic raphe neurons.Thusregulation of the 5-HT1A receptor gene could play a crucial role in thetreatment oretiology of major depression. The promoter and repressor activities of thehuman5-HT1A receptor gene have been examined. The analysis of the 5'-flankingregions of the5-HT1A receptor gene has revealed a segment located between about -3438 andabout-393 bp upstream from the initiator ATG that mediates cell-specific repressionof thegene that is greater in cells that do not express the 5-HT1A receptor. Thesequence ofpart of this region in patients with major depression was examined and apolymorphicC-G change located at -1019 bp (numbered earlier as -1017) was identified,which isassociated with major depression. Thus, this sequence can be used as a geneticmarkerfor major depression and related mental illnesses. Proteins that bind to theDNA at the-1019 locus have been identified. Such proteins that bind to this DNA region,forexample the transcription factors NUDR/DEAF-1/suppressin and HES-5, areimportanttargets for the development of therapeutic compounds for the treatment ofmajordepression and related mental illness that involve the serotonin system. Inaddition thepromoter region from about -393 to the initiator ATG displays glucocorticoid-mediatedrepression.
机译:抗抑郁药的临床反应与选择性5-羟色胺神经元神经元中突触前5-HT1A受体的下调。从而5-HT1A受体基因的调控可能在治疗或抑郁症的病因。的启动子和阻遏活性人的已经检查了5-HT1A受体基因。 5'侧翼分析的区域5-HT1A受体基因揭示了一个位于大约-3438和关于启动子ATG上游-393 bp,介导细胞特异性阻遏的该基因在不表达5-HT1A受体的细胞中更大。的的顺序对重度抑郁患者的这一区域的一部分进行了检查,多态的确定了位于-1019 bp(之前编号为-1017)的C-G变化,这是与严重的抑郁症有关。因此,该序列可用作遗传记号笔适用于严重抑郁症和相关的精神疾病。与蛋白质结合的蛋白质DNA在已确定-1019个基因座。结合到该DNA区域的蛋白质对于例如,转录因子NUDR / DEAF-1 / suppressin和HES-5是重要开发用于治疗下列疾病的治疗性化合物的目标重大的涉及5-羟色胺系统的抑郁症和相关的精神疾病。在除了从大约-393到启动子ATG的启动子区域显示糖皮质激素-介导的抑制。

著录项

  • 公开/公告号CA2473337A1

    专利类型

  • 公开/公告日2005-02-05

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF OTTAWA;

    申请/专利号CA20042473337

  • 发明设计人 ALBERT PAUL;LEMONDE SYLVIE;

    申请日2004-07-09

  • 分类号C12N15/12;C07K16/18;C12Q1/68;G01N33/53;

  • 国家 CA

  • 入库时间 2022-08-21 22:14:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号